Exercise therapy for people with axial spondyloarthritis
Official title: EXercise As an Anti-inflammatory Treatment in Axial Spondyloarthritis (axSpA) for Patients Taking Biologic Therapy: a Proof of Concept Study (ExTASI-B).
Run by Loughborough University · NCT06669702 · Data updated 2026-11-12
This study is testing if a 12-week home-based walking program can help people with axial spondyloarthritis feel better and improve their overall health while they are already on medication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Loughborough University Academic / other |
| Locations | 2 sites (Loughborough, Leicestershire and 1 other locations) |
| Status | Recruiting |
| Started | August 1, 2024 |
| Main results expected | September 30, 2027 |
| Study ends | July 31, 2029 |
| Registry record updated | November 5, 2024 |
| Trial ID | NCT06669702 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older diagnosed with axial spondyloarthritis who are stable on biologic treatment.
✕Probably not a fit
Patients unable to exercise due to physical or psychological barriers or those with significant cardiovascular comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of a 12-week structured home-based aerobic exercise program on individuals with axial spondyloarthritis who are already receiving biologic therapy. The study aims to determine if brisk walking can improve quality of life, reduce symptoms, and lower markers of immune-mediated inflammation. Additionally, it will assess the acceptability of the intervention through participant feedback and evaluate its impact on cardiometabolic health and body composition. The trial will involve 40 participants, with half receiving the exercise intervention and the other half continuing routine care.
Why it matters
Potential benefit: If successful, this intervention could enhance the quality of life and reduce disease burden for patients with axial spondyloarthritis.
How similar studies have gone: Previous studies have shown that exercise can lower inflammatory markers in other patient groups, suggesting potential success for this approach in axial spondyloarthritis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of axSpA by a consultant rheumatologist * Age=/\>18 years old * Without other significant cardiovascular comorbidities * Receiving stable dose biologic treatment * Able to commit to the time demands of the study Exclusion Criteria: * Unable to undertake exercise due to physical or psychological barriers * Presence of hip or peripheral joint disease * Contraindication to exercise training (American College of Sports Medicine guidelines) * Excessively active (score of high on IPAQ) * Unable to communicate sufficiently in English * Female participants who are pregnant, lactating, or planning pregnancy during the course of the study. * Inability to give informed consent or comply with testing and training protocol for any reason. * Presence of chronic anaemia (haemoglobin less than 13.5 g/dL for men; less than 12.0 g/dL for women; or haematocrit less than 41.0% in men, less than 36.0% in women. * Co-morbidity that the research team determine to be a contraindication to involvement Inclusion and exclusion criteria of healthy controls: Inclusion Criteria: * Aged between 18 years old and 65 years old * Not taking any long-term medication that affects inflammation or immune-mediated inflammation. * Free from infection or infection symptoms Exclusion criteria: The participant may not enter the study if ANY of the following apply: * Unable to undertake exercise due to physical or psychological barriers * Excessively active (score of high on IPAQ) * Unable to communicate sufficiently in English * Female participants who are pregnant, lactating, or planning pregnancy during the course of the study. * Inability to give informed consent or comply with testing and training protocol for any reason. * Have been diagnosed with or are aware of at least one of the following health issues: * Immune system disorder * Cardiovascular and/or cardiometabolic diseases, including but not limited to high blood pressure, high triglycerides and/or cholesterol levels, diabetes mellitus, etc. * Any chronic health condition that affects one's ability to partake in physical activity * Musculoskeletal injury that affects one's ability to partake in physical activity
Where it's running
-
Loughborough University, National Centre for Sport and Exercise Medicine
Loughborough, Leicestershire, United Kingdom Recruiting -
University Hospitals of Leicester NHS trust
Leicester, United Kingdom, United Kingdom Recruiting
Study contacts
- Principal investigator: Arumugam Moorthy, Dr — University Hospitals, Leicester
- Study coordinator: Nicolette C Bishop, PhD
- Email: N.C.Bishop@lboro.ac.uk
- Phone: 01509226385
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Ultrasound Before Corticosteroid Injection for Arthritis
This trial tests whether applying ultrasound before a corticosteroid joint injection helps improve arthritis symptoms in adults with limb arthritis who need an injection.
-
Ultralow-dose PET scan to detect bone activity with 18F‑NaF
This trial tests whether a new high-sensitivity PET scan using a tiny amount of 18F‑sodium fluoride can produce clear bone images in adults with or without bone disease while cutting radiation exposure by 10–100 times.
-
Early stratification of acute arthritis
The project will collect clinical information and biomarker samples to try to find signs that help classify and guide treatment for adults who developed inflammatory arthritis symptoms within the past 12 weeks.
-
Biophoton therapy for chronic severe arthritis pain relief
This study is testing if biophoton therapy can help people with chronic severe arthritis pain feel better over 12 weeks.
-
Examining the effects of different exercise levels on arthritis symptoms
This study tests how different amounts of exercise can help people with arthritis feel better over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.